diet therapy for celiac disease

... investigation for clinical conditions compatible with celiac disease (anemia, short stature, and abdominal pains) (35) . Celiac disease is a cause of short stature that should not be forgotten, ... methods with good sensitivity and specicity for the screening and diagnosis of celiac patients. The anti-tTG assay emerged as a great hope for celiac disease screening, since it is an easily-executed ... may reduce the number of cases positive for celiac disease, particularly where villous atrophy is less severe (14,25,26) . Seronegative cases of celiac disease do occur; these patients have a...

Ngày tải lên: 12/02/2014, 19:20

... or end-stage renal failure [8]. The prevalence of Fabry disease is estimated at 1 : 40 000 for the classic form. The incidence of the variant form of Fabry disease was found to be higher. Screening of various ... weightặday )1 for 2 weeks [47]. No apparent toxic effects were observed in transgenic mice treated with DGJ for 140 days, indicating that DGJ is well toler- ated in mice. ASSC therapy for Fabry disease ... quality of life. Perspective of DGJ treatment for Fabry disease To date, ERT is the only available Food and Drug Administration approved therapy for Fabry disease. ERT has clear advantages in that...

Ngày tải lên: 30/03/2014, 03:20

... Ideally, however, gene therapy can be accomplished to correct genetic defects by in vivo methods. Ideally, a vehicle for in vivo gene therapy for the treatment of liver disease must be liver specific, ... acquired diseases such as viral infections of the liver. ã There are two basic approaches for gene transfer into hepatocytes: ex vivo and in vivo strategies. ã A vehicle for in vivo gene therapy for ... days posttreatment. The decline lasted for approximately 2 weeks, after which there was a gradual rise in DNA levels. 172 GENE THERAPY FOR LIVER DISEASE therapy is that only dividing cells are...

Ngày tải lên: 10/04/2014, 22:11

Ngày tải lên: 08/08/2014, 21:20

Ngày tải lên: 09/08/2014, 10:20

Ngày tải lên: 10/08/2014, 11:20

Ngày tải lên: 14/08/2014, 19:22

... mixed diet, the patient is given medicines for the relief of pain, or for the reduction of temperature, stimulants or sedatives for the heart, cathartics for the bowels or diuretics for the ... I am not afraid to give the milk diet in any case of diseased blood vessels, or in aneurism caused by disease, for I believe the blood carries its own cure for these conditions, but COMPLETE ... varied diet, by taking the milk treatment for a few weeks.” Where it is the intention of patients to keep on with the milk diet for very long after stopping the rest cure, it is advisable for...

Ngày tải lên: 15/03/2014, 00:20

Ngày tải lên: 18/06/2014, 16:20

... 4. Eligibility standard for oral rehydration therapy I. Patients eligible for oral rehydration therapy (receiving oral rehydration solution) 1. Those who give an informed consent and have not ... an oxygen therapy at home for chronic obstructive respiratory disease, was in grade III of the ASA physical status classification and, basically, was not the patient ap- propriate for the ORT ... and electrolyte management is usually performed by intravenous therapy. We investigated the safety and effectiveness of oral rehydration therapy (ORT) for preoperative fluid and electrolyte...

Ngày tải lên: 25/10/2012, 10:51

... vaccination in combination with imatinib therapy for a CML patient. A 51 year-old male with CML in CP, who showed a resistance against imatinib therapy for 2.5 years, began to be treated with ... μg/ml for l antibody periments Int. J. Med. Sc Figure 2. WT performed in a the 20th admi PE-modified-t y for WT1 pept peptide/MHC 3. Kinetics o Comple blood cell dif WT1 peptid therapy. ... anti-tumor immunotherapy as in this case. These data suggested the possible usefulness of treatment for suppressing the function of regulatory T cells in combination with anti-tumor immunotherapy in- cluding...

Ngày tải lên: 26/10/2012, 09:39

... not yet been obtained in therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome (APS). We therefore compared single antiplatelet therapy and a combination ... in the single antiplatelet therapy group, and one subcutaneous hemorrhage was found in the combination therapy group. As for the patient in the single antiplatelet therapy group who developed ... assigned to either single antiplatelet therapy (aspirin 100 mg) or a combination of antiplatelet and an- ticoagulation therapy (target INR: 2.0-3.0; mean 2.4±0.3) for the secondary prevention of stroke...

Ngày tải lên: 26/10/2012, 09:48

... effects. 320 Therapy of Selected Diseases Lüllmann, Color Atlas of Pharmacology â 2000 Thieme All rights reserved. Usage subject to terms and conditions of license. Therapy of Selected Diseases ... cannot be ruled out. Therefore, monotherapy with β-blockers is recom- mended only in angina due to coronary sclerosis, but not in variant angina. 308 Therapy of Selected Diseases Lüllmann, Color ... symptoms). 312 Therapy of Selected Diseases Lỹllmann, Color Atlas of Pharmacology â 2000 Thieme All rights reserved. Usage subject to terms and conditions of license. Therapy of Selected Diseases...

Ngày tải lên: 15/12/2013, 13:15

Ngày tải lên: 19/02/2014, 22:20